Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Medivation Announces Participation at Upcoming Investor Conference


Medivation Announces Participation at Upcoming Investor Conference

SAN FRANCISCO, CA -- (Marketwire) -- 02/06/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:


 
--  Patrick Machado, chief business and financial officer, will present at
    the Leerink Swann Global Healthcare Conference on February 13 at
    8:30am ET in New York, NY.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.

Contacts: Patrick Machado Chief Business & Financial Officer (415) 829-4101

Anne Bowdidge Sr. Director, Investor Relations (650) 218-6900

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement